Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 19
2015 30
2016 31
2017 17
2018 25
2019 19
2020 19
2021 17
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

166 results
Results by year
Filters applied: . Clear all
Page 1
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.
Di Mauro S, Scamporrino A, Petta S, Urbano F, Filippello A, Ragusa M, Di Martino MT, Scionti F, Grimaudo S, Pipitone RM, Privitera G, Di Pino A, Scicali R, Valenti L, Dongiovanni P, Fracanzani A, Rabuazzo AM, Craxì A, Purrello M, Purrello F, Piro S. Di Mauro S, et al. Liver Int. 2019 Sep;39(9):1742-1754. doi: 10.1111/liv.14167. Epub 2019 Jun 26. Liver Int. 2019. PMID: 31169972 Free PMC article.
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
Zheng KI, Liu WY, Pan XY, Ma HL, Zhu PW, Wu XX, Targher G, Byrne C, Wang XD, Chen YP, Lu F, Zheng MH. Zheng KI, et al. BMJ Open Diabetes Res Care. 2020 Mar;8(1):e001174. doi: 10.1136/bmjdrc-2020-001174. BMJ Open Diabetes Res Care. 2020. PMID: 32139603 Free PMC article.
Noninvasive Diagnosis of NAFLD and NASH.
Piazzolla VA, Mangia A. Piazzolla VA, et al. Cells. 2020 Apr 17;9(4):1005. doi: 10.3390/cells9041005. Cells. 2020. PMID: 32316690 Free PMC article. Review.
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions.
Notarnicola M, Osella AR, Caruso MG, Pesole PL, Lippolis A, Tutino V, Bonfiglio C, De Nunzio V, Scavo MP, Mirizzi A, Franco I, Lippolis T, D'Alessandro R, Refolo MG, Messa C. Notarnicola M, et al. Int J Mol Sci. 2021 Apr 9;22(8):3899. doi: 10.3390/ijms22083899. Int J Mol Sci. 2021. PMID: 33918878 Free PMC article. Review.
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH.
Boursier J, Anty R, Vonghia L, Moal V, Vanwolleghem T, Canivet CM, Michalak S, Bonnafous S, Michielsen P, Oberti F, Iannelli A, Van Gaal L, Patouraux S, Blanchet O, Verrijken A, Gual P, Rousselet MC, Driessen A, Hunault G, Bertrais S, Tran A, Calès P, Francque S. Boursier J, et al. Aliment Pharmacol Ther. 2018 May;47(10):1387-1396. doi: 10.1111/apt.14621. Epub 2018 Mar 25. Aliment Pharmacol Ther. 2018. PMID: 29577364 Clinical Trial.
166 results